Home/Filings/4/0001415889-24-006811
4//SEC Filing

Chaubey Alka 4

Accession 0001415889-24-006811

CIK 0001411690other

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 5:48 PM ET

Size

5.9 KB

Accession

0001415889-24-006811

Insider Transaction Report

Form 4
Period: 2024-02-15
Chaubey Alka
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2024-02-15$1.27/sh1,081$1,37331,487 total
Footnotes (3)
  • [F1]The reporting person is reporting the withholding by the Issuer of an aggregate of 1,081 shares of common stock in connection with shares that vested on February 15, 2024 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.
  • [F2]On August 4, 2023, the common stock of Bionano Genomics, Inc. split 1-for-10, resulting in the reporting person's ownership of 112,315 less shares of common stock.
  • [F3]Includes 89 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 12, 2023.

Issuer

Bionano Genomics, Inc.

CIK 0001411690

Entity typeother

Related Parties

1
  • filerCIK 0001821605

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:48 PM ET
Size
5.9 KB